Since our studies demonstrate that GAS41-mediated histone binding is critical for its effects on NRF2-dependent transactivation, it will be interesting to examine whether the combination of those small molecule inhibitors of GAS41 (or loss of GAS41) and ferroptosis inducers may have synergistic effects in tumor suppression for potential cancer therapy. Here, NFE2L2 is linked to neoplasm.